Skip to main content
Back to Korea Investment Partners

Korea Investment Partners's Pharmaceutical Portfolio

Browse 20 Pharmaceutical companies funded by Korea Investment Partners. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
20
Total Funding in Pharmaceutical
$210.9M

Pharmaceutical Portfolio Companies (20)

Export
BiotechnologyManufacturingPharmaceutical

Pin Therapeutics is a pharmaceutical startup focusing on advanced protein degradation therapeutics.

Seongnam, South Korea
December 2024
$13.6M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalTherapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Plymouth Meeting, United States
September 2023
$5.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareOncologyPharmaceutical

Prokarium is biopharmaceutical company leading the oncology field of microbial immunotherapy.

London, United Kingdom
February 2023
$30.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical DevicePharmaceuticalPrecision Medicine

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.

Waltham, United States
March 2022
$30.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Medical DevicePharmaceutical

LabInCube develops inCube materials capable of selective drug release, sustained release, and supporting complex raw materials.

Cheongju, South Korea
December 2025
Corporate Round

Founder Contacts

41,000+ verified contacts

Health CareMedicalMedical DevicePharmaceutical

Kangdesai Medical Technology is engaged in the development, transformation, and application of new cell therapy technologies.

Chengdu, China
September 2025
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases.

Seoul, South Korea
August 2025
$3.6M
Series B

Founder Contacts

41,000+ verified contacts

PetPharmaceutical

Petpharma is an Operator of an e-commerce platform intended to provide veterinary medicines.

Seongnam, South Korea
February 2025
$4.5M
Series B

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMedicalPharmaceutical

Selta Square is an AI-based drug monitoring company that offers full-cycle drug monitoring solutions using AI technology.

Seoul, South Korea
January 2025
$6.4M
Series A

Founder Contacts

41,000+ verified contacts

AppsDietary SupplementsMobile AppsNutritionPharmaceutical

MyHerb Healthcare proivdes a specialized analysis for nutritional supplements.

Seoul, South Korea
January 2025
$2.9M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Mepsgen is a biotechnology research organization that focuses on pharmaceutical services and drug development.

Seoul, South Korea
November 2024
$14.9M
Series C

Founder Contacts

41,000+ verified contacts

DentalE-CommerceMedical DevicePharmaceutical

Kangjian Miaomiao is an e-commerce platform that specializes in the production of full-category, customized oral and dental products.

Hangzhou, China
June 2024
$13.8M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyManufacturingPharmaceutical

Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing and R&D company.

Shanghai, China
January 2024
Private Equity

Founder Contacts

41,000+ verified contacts

Alternative MedicineChemicalPharmaceutical

This company is a new name for the plasma business of SK chemicals.

Pangyo, South Korea
October 2023
$49.8M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

Biomatz is a biotech company developing AI-driven microbiome therapeutics using cooperative multi-strain design.​

Seoul, South Korea
June 2023
$1.5M
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalNeurosciencePharmaceutical

S&E Bio is a biopharmaceutical company that develops cell therapies for neurological disorders.

Seoul, South Korea
November 2022
$7.7M
Series A

Founder Contacts

41,000+ verified contacts

Health CareMedicalPharmaceutical

Oncobix is a drug company that researches and develops drugs for rare and incurable diseases.

Yongsin, South Korea
September 2022
$2.8M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyManufacturingPharmaceutical

Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.

Shanghai, China
August 2022
$14.7M
Series C

Founder Contacts

41,000+ verified contacts

Health CareHealth DiagnosticsMedicalPharmaceutical

Otus is a healthcare institute that specializes in advanced eyecare system.

Seongsan, South Korea
February 2022
$833K
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsLife SciencePharmaceutical

TSD Life Sciences is a bio company that provides clinical research services to defeat cancer through research and development.

Seoul, South Korea
June 2021
$8.8M
Series A

Founder Contacts

41,000+ verified contacts

Explore Korea Investment Partners's Full Portfolio

View all companies funded by Korea Investment Partners across every industry and funding stage.

View Full Korea Investment Partners Portfolio